Literature DB >> 1374094

Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.

M T Kasaian1, H Ikematsu, P Casali.   

Abstract

The production of "natural" autoantibodies or antibodies, i.e., Ig that bind a variety of self- and/or exogenous Ag and arise independently of known immunization, is though to be a feature of CD5+ B lymphocytes. To determine whether other lymphocyte subsets exist that might be committed to the production of natural antibodies, human peripheral blood B cells were sorted on the basis of surface CD5 expression and differential expression of surface CD45RA (CD5+CD45RAintermediate(int), CD5-CD45RAlow(lo), and CD5-CD45RAhigh(hi)), and analyzed for the type of Ig produced after EBV infection and culture. Like their CD5+ counterparts, most CD5-CD45RAlo B lymphocytes were precursors of cells producing IgM, a major proportion of which displayed the Ag-binding features of natural antibodies. In contrast, CD5-CD45RAhi B cells comprised a high frequency of IgG-producing cell precursors, possibly including memory B lymphocytes. Six of seven IgM mAb generated from sorted CD5-CD45RAlo B cells and three of four IgM mAb from sorted CD5+ B cells were polyreactive, binding with different affinities (Kd, 10(-5) to 10(-8) M) to two or more Ag; the remaining mAb from CD5-CD45RAlo and the mAb from CD5+ B cells each bound to a single Ag (Kd, 10(-7) to 10(-8) M), beta-galactosidase and ssDNA, respectively. CD5-CD45RAlo B cells account for 4.1 +/- 1.2% (mean +/- SD in 11 healthy subjects; CD5+ B cells, 23.3 +/- 6.9%) of total B lymphocytes and display the features of quiescent cells. In a given individual, the number of CD5-CD45RAlo B cells remains constant over time. CD5-CD45RAlo and CD5+ B cells bear surface CD11b and CD14, at densities and/or frequencies apparently higher than those of CD5-CD45RAhi B lymphocytes. Despite their surface CD5- phenotype, CD45RAlo B cells express CD5+ mRNA at levels comparable with those of CD5+ B lymphocytes, whereas CD5-CD45RAhi B cells express only trace amounts of CD5 mRNA. The commitment to natural antibody production and the degree of CD5 mRNA expression suggest that the newly defined CD5-CD45RAlo B cell subset is related to CD5+ B lymphocytes, and may constitute the human homologue of the mouse Ly-1-"sister" B cell population.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374094      PMCID: PMC4626883     

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  64 in total

1.  Somatic mutations in the VH genes of high-affinity antibodies to self and foreign antigens produced by human CD5+ and CD5- B lymphocytes.

Authors:  H Ikematsu; N Harindranath; P Casali
Journal:  Ann N Y Acad Sci       Date:  1992-05-04       Impact factor: 5.691

Review 2.  The development and repertoire of B-1 cells (CD5 B cells).

Authors:  A B Kantor
Journal:  Immunol Today       Date:  1991-11

Review 3.  CD5+ B lymphocytes.

Authors:  M T Kasaian; H Ikematsu; P Casali
Journal:  Proc Soc Exp Biol Med       Date:  1991-07

Review 4.  The genetic origin of human autoantibodies.

Authors:  I Sanz; J D Capra
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

5.  Expression and regulation of CD5 on in vitro activated human B cells.

Authors:  A S Freedman; G Freeman; J Whitman; J Segil; J Daley; H Levine; L M Nadler
Journal:  Eur J Immunol       Date:  1989-05       Impact factor: 5.532

6.  Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways.

Authors:  Y Z Cong; E Rabin; H H Wortis
Journal:  Int Immunol       Date:  1991-05       Impact factor: 4.823

7.  Monoclonal autoantibodies against mouse red blood cells: a family of structurally restricted molecules.

Authors:  P Poncet; H P Kocher; J Pages; J C Jaton; A E Bussard
Journal:  Mol Immunol       Date:  1985-05       Impact factor: 4.407

8.  Murine monoclonal anti-DNA autoantibodies bind to endogenous bacteria.

Authors:  P Carroll; D Stafford; R S Schwartz; B D Stollar
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

9.  CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells.

Authors:  J A Ledbetter; N K Tonks; E H Fischer; E A Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Progenitors for Ly-1 B cells are distinct from progenitors for other B cells.

Authors:  K Hayakawa; R R Hardy; L A Herzenberg; L A Herzenberg
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

View more
  42 in total

1.  Activation of bovine B cells via surface immunoglobulin M cross-linking or CD40 ligation results in different B-cell phenotypes.

Authors:  K M Haas; D M Estes
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

2.  CD5 expression by B lymphocytes and its regulation upon Epstein-Barr virus transformation.

Authors:  D Kaplan; D Smith; H Meyerson; N Pecora; K Lewandowska
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

3.  Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-1+ and B-1- phenotypes.

Authors:  Z-H Zhou; A L Notkins
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 4.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

5.  Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract.

Authors:  Cordelia Manickam; Chiadika Nwanze; Daniel R Ram; Spandan V Shah; Scott Smith; Rhianna Jones; Brady Hueber; Kyle Kroll; Valerie Varner; Paul Goepfert; Stephanie Jost; R Keith Reeves
Journal:  AIDS       Date:  2018-07-31       Impact factor: 4.177

6.  Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors.

Authors:  L Mantovani; R L Wilder; P Casali
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

7.  FcμR in human B cell subsets in primary selective IgM deficiency, and regulation of FcμR and production of natural IgM antibodies by IGIV.

Authors:  Sudhir Gupta; Sudhanshu Agrawal; Sastry Gollapudi; Hiromi Kubagawa
Journal:  Hum Immunol       Date:  2016-10-14       Impact factor: 2.850

8.  Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments.

Authors:  P Riboldi; G Gaidano; E W Schettino; T G Steger; D M Knowles; R Dalla-Favera; P Casali
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

9.  De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.

Authors:  A Matolcsy; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

10.  Role of CD5+ B-1 cells in EAE pathogenesis.

Authors:  Lisa K Peterson; Ikuo Tsunoda; Robert S Fujinami
Journal:  Autoimmunity       Date:  2008-08       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.